Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoladex versus Zoladex + Nolvadex in pre/perimenopausal advanced breast cancer
ACTRN12606000499583Phase 3Completed
- Sponsor
- Breast Cancer Trials
- Start
- Feb 1989
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of goserelin and tamoxifen in breast cancer, sponsored by Breast Cancer Trials. Started Feb 1989; status: completed.
02
Drugs
goserelintamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on ACTRN12606000499583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000499583.